LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease

Area of Science:

• Neuroscience
• Genetics
• Pathology

Background:

• Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a leading genetic cause of Parkinson's disease (PD).
• LRRK2-associated PD shares pathological similarities with sporadic PD, highlighting LRRK2 as a therapeutic target.
• LRRK2 plays a crucial role in the pathogenesis of Parkinson's disease.

Purpose of the Study:

• To review the utility of LRRK2 mutant knock-in (KI) mouse models in understanding Parkinson's disease pathogenesis.
• To discuss the implications of findings from LRRK2 KI mouse models for PD research.
• To explore therapeutic strategies targeting LRRK2-associated pathologies in Parkinson's disease.

Main Methods:

• Review of existing literature on LRRK2 mutant knock-in (KI) mouse models.
• Analysis of pathological and symptomatic parallels between LRRK2 KI mice and Parkinson's disease patients.
• Evaluation of LRRK2's role in neurodegeneration and disease progression.

Main Results:

• LRRK2 KI mouse models exhibit early-stage PD-like alterations, including nigrostriatal pathway defects, motor/non-motor symptoms, and mitochondrial dysfunction.
• These models recapitulate key pathological features such as synucleinopathies and autophagy-lysosomal impairments.
• Findings underscore the relevance of LRRK2 in PD pathogenesis.

Conclusions:

• LRRK2 KI mice are valuable tools for investigating LRRK2-mediated Parkinson's disease pathogenesis.
• Current research in LRRK2 KI models provides critical insights into disease mechanisms.
• Targeting LRRK2 presents a promising therapeutic avenue for Parkinson's disease.